Cargando…
Allergen‐specific immunotherapy by recombinant Der P1 allergen‐derived peptide‐based vaccine in an allergic mouse model
AIM: Increased IgE levels have made house dust mite allergens one of the most frequent causes of allergies worldwide. Treatment reduces the IgE antibodies and types two cytokines, namely interleukin‐4 (IL‐4) and IL‐13. Although existing treatments significantly reduce IgE or IL‐4/IL‐13, they are ver...
Autores principales: | Asoudeh Moghanloo, Soheila, Forouzanfar, Mohsen, Jafarinia, Mojtaba, Fazlollahi, Mohammad R., Kardar, Gholam Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251762/ https://www.ncbi.nlm.nih.gov/pubmed/37382249 http://dx.doi.org/10.1002/iid3.878 |
Ejemplares similares
-
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014) -
Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases
por: Zahirović, Abida, et al.
Publicado: (2018) -
Analysis of predicted B and T-cell epitopes in Der p 23, allergen from Dermatophagoides pteronyssinus
por: Fanuel, Songwe, et al.
Publicado: (2017) -
Immunotherapy with Allergen Peptides
por: Larché, Mark
Publicado: (2007) -
Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020)